Request Deal Involvement
QIAGEN completed the acquisition of an 80.1% stake in NeuMoDx Molecular for $248m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Jefferies & Company
legal advisors
Mintz Levin
pr advisors
Kekst CNC
or
Principals
vendor
PFIZER VENTURES
vendor
BAIRD CAPITAL
target
NEUMODX MOLECULAR INC
bidder
QIAGEN NV
vendor
VENTURE INVESTORS
vendor
ARBORETUM VENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite